Tata Elxsi Launches a Global Offshore Development Centre (ODC) for Terumo
Thursday, March 19, 2026
.jpg)
Tata Elxsi, a provider of design and technology services and Terumo, a medical innovation company, have inaugurated the ‘Terumo–Tata Elxsi Offshore Development Centre’. This dedicated centre will support the development of Terumo’s cardiac and vascular solutions, strengthening engineering and innovation capabilities, while enabling continuous lifecycle support across international markets. Contd
The centre brings together multidisciplinary teams, with Tata Elxsi’s expertise in design, engineering, verification, regulatory compliance and localisation, along with the thoughtful application of AI, GenAI and digital capabilities in software engineering. This enables faster development and regional adaptation while addressing the growing demand for patient-centric medical devices with improved cost efficiency and product differentiation.
The collaboration advances the reliability and performance of cardiac and vascular technologies, supporting their global availability and helping ensure they meet industry standards and the evolving needs of healthcare providers and patients.
Fumihisa Hirose, Company President, Cardiac & Vascular Company, Terumo Corporation said, “This new Offshore Development Centre strengthens our ability to innovate faster and deliver high-quality medical technologies across global markets. Tata Elxsi’s integrated design, engineering and regulatory expertise will help us accelerate our global product road map while maintaining the highest standards of safety and compliance.”
Sreevatsa Sahasranaman, Sr VP & Head, Healthcare & Life Sciences, Tata Elxsi said, “This Offshore Development Centre represents a comprehensive long-term partnership model with Terumo Corporation to bring Tata Elxsi’s multi-disciplinary, cross-functional and deep domain expertise to drive innovation and cost efficiencies across Terumo’s Cardiovascular portfolio. We are committed to combining design, engineering and regulatory capabilities, enhanced by the latest AI- and GenAI-powered technologies, to help Terumo bring next-gen medical technologies to global and emerging markets.”
